May 10 2024University of California - Los Angeles Health Sciences
We have previously shown that chemotherapy can contribute to a decline in physical function in breast cancer survivors, but it wasn't fully understood if the decline was primarily driven by the cancer, chemotherapy or both. It's important to have this comparison to determine whether or not this decline represents an acceleration of the aging process itself."
To better understand the impact of breast cancer treatment on aging-related decline in physical function, the team performed a multicenter prospective study that compared the changes in physical function over time in women over the age of 65. Participants included 444 women with early-stage breast cancer receiving chemotherapy, 98 women with early-stage breast cancer not receiving chemotherapy, and 100 women without cancer of the same age.
Related StoriesAmong the participants who experienced a substantial decline, the activity most adversely affected was climbing several stairs , followed by walking one mile and engaging in moderate activity .
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Combination of breast cancer and chemotherapy may speed up physical decline in older adultsA UCLA-led study suggests that women who are 65 years old or older with high-risk breast cancer and are treated with chemotherapy are more likely to develop a substantial decline in physical function.
Source: medical_xpress - 🏆 101. / 51 Read more »
Radiotherapy with hormone therapy can help some advanced prostate cancer patients avoid chemotherapyRadiotherapy can be used alongside hormone treatment, delaying the need for chemotherapy and therefore significantly protecting their quality of life for some patients with advanced prostate cancer, according to researchers from The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London.
Source: medical_xpress - 🏆 101. / 51 Read more »
Transfected SARS-CoV-2 spike DNA suppresses cancer cell response to chemotherapySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 infection has led to worsened outcomes for patients with cancer. SARS-CoV-2 spike protein mediates host cell infection and cell-cell fusion that causes stabilization of tumor suppressor p53 protein.
Source: medical_xpress - 🏆 101. / 51 Read more »
Unraveling the roles of non-coding DNA explains childhood cancer's resistance to chemotherapySt. Jude Children's Research Hospital scientists have identified specific DNA variants in the non-coding regions of the genome contributing to chemotherapy resistance in acute lymphoblastic leukemia (ALL). The results guided the team to unravel the mechanism behind a previously unknown contributor to therapeutic resistance.
Source: medical_xpress - 🏆 101. / 51 Read more »
'It saved a lot of my hair during chemotherapy' – breast cancer patients praise cooling capsA trio of women who were all in their early 30s or under when diagnosed with breast cancer have given a boost to other patients going through treatment – thanks to the donation of additional equipment designed to prevent hair loss.
Source: ShropshireStar - 🏆 98. / 51 Read more »
New system personalizes chemotherapy doses for cancer patientsWhen cancer patients undergo chemotherapy, the dose of most drugs is calculated based on the patient's body surface area. This is estimated by plugging the patient's height and weight into an equation, dating to 1916, that was formulated from data on just nine patients.
Source: NewsMedical - 🏆 19. / 71 Read more »